The impact of uncertainty in hERG binding mechanism on in silico predictions of drug‐induced proarrhythmic risk
British Journal of Pharmacology · 2024-04 · 181 (7) · 987-1004
DOI: 10.1111/bph.16250 ↗At a glance
Journal article in British Journal of Pharmacology, published online on 2023-11-08. Written by Chon Lok Lei and 2 co-authors. Institution: Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, China. Major MEDLINE topics: Ether-A-Go-Go Potassium Channels, Arrhythmias, Cardiac. Cited 11 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Fundo para o Desenvolvimento das Ciências e da Tecnologia.
Abstract (original language)
Background and Purpose Drug‐induced reduction of the rapid delayed rectifier potassium current carried by the human Ether‐à‐go‐go‐Related Gene (hERG) channel is associated with increased risk of arrhythmias. Recent updates to drug safety regulatory guidelines attempt to capture each drug's hERG binding mechanism by combining in vitro assays with in silico simulations. In this study, we investigate the impact on in silico proarrhythmic risk predictions due to uncertainty in the hERG binding mechanism and physiological hERG current model. Experimental Approach Possible pharmacological binding models were designed for the hERG channel to account for known and postulated small molecule binding mechanisms. After selecting a subset of plausible binding models for each compound through calibration to available voltage‐clamp electrophysiology data, we assessed their effects, and the effects of different physiological models, on proarrhythmic risk predictions. Key Results For some compounds, multiple binding mechanisms can explain the same data produced under the safety testing guidelines, which results in different inferred binding rates. This can result in substantial uncertainty in the predicted torsade risk, which often spans more than one risk category. By comparison, we found that the effect of a different hERG physiological current model on risk classification was subtle. Conclusion and Implications The approach developed in this study assesses the impact of uncertainty in hERG binding mechanisms on predictions of drug‐induced proarrhythmic risk. For some compounds, these results imply the need for additional binding data to decrease uncertainty in safety‐critical applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, China.
- Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macau, China.
- Centre for Mathematical Medicine & Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, UK.
ORCID profiles: Chon Lok Lei, Dominic G Whittaker, Gary R Mirams
Funding
- Wellcome Trust
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
Cite
APA
Lei, C. L., Whittaker, D. G., & Mirams, G. R. (2024). The impact of uncertainty in hERG binding mechanism on in silico predictions of drug‐induced proarrhythmic risk. British Journal of Pharmacology, 181(7), 987-1004. https://doi.org/10.1111/bph.16250
Vancouver
Lei CL, Whittaker DG, Mirams GR. The impact of uncertainty in hERG binding mechanism on in silico predictions of drug‐induced proarrhythmic risk. British Journal of Pharmacology. 2024;181(7):987-1004. doi:10.1111/bph.16250
BibTeX
@article{Lei2024,
author = {Lei, Chon Lok and Whittaker, Dominic G and Mirams, Gary R},
title = {The impact of uncertainty in hERG binding mechanism on in silico predictions of drug‐induced proarrhythmic risk},
journal = {British Journal of Pharmacology},
year = {2024},
volume = {181},
number = {7},
pages = {987--1004},
doi = {10.1111/bph.16250}
}
EUVIMED